Ikonisys SA has partnered with Biocare Medical, a leader in immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) tools and reagents. This alliance focuses on expanding the global distribution of the low volume Ikoniscope20 and high volume Ikoniscope20max, the fully automated instruments for FISH slides analysis manufactured by Ikonisys. Biocare Medical's recent acquisition of Empire Genomics has expanded their offering to include over 1 million FISH probes.

With this significant augmentation in their FISH probe library, a collaboration with Ikonisys, which provides an advanced fluorescence microscope, becomes even more strategic. Biocare Medical stands out with a comprehensive portfolio encompassing IHC, molecular reagents, tissue-conserving multiplex solutions, and a suite of advanced instruments across clinical, research, and biopharma sectors. The collaboration between Ikonisys and Biocare Medical aims to provide an all-encompassing solution, merging an unlimited menu of clinical and research FISH probes with fluorescent slide digitization and analysis via the Ikoniscope platform.

This partnership's objective is to broaden the reach of innovative technologies, equipping healthcare professionals with more refined diagnostic tools in regions including the U.S., Europe, and most of Asia-Pacific. By leveraging Biocare Medical's distribution channels, which span over 4,000 global laboratories, Ikonisys can direct its resources on expanding its product portfolio.